Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N I Nissen

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Ugeskrift for Laeger|June 25, 1973
[Vincristine sulfas (Oncovin), a cytostatic agent]N I Nissen
Antibiotics and Chemotherapy|January 1, 1978
Chemotherapy with or without radiotherapy in malignant lymphomasN I Nissen
Ugeskrift for Laeger|June 19, 1972
[Evaluation of the clinical effect of antineoplastic drugs]N I Nissen
Nordisk Medicin|April 22, 1971
[Clinically controlled research in tumor chemotherapy]N I Nissen
European Journal of Haematology|July 1, 1988
Prognostic factors in Hodgkin's disease stage III with special reference to tumour burdenL Specht, N I Nissen
Ugeskrift for Laeger|June 19, 1972
[Vinca alkaloids, a newer group of anti-neoplastic drugs]I Hansen, N I Nissen
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|September 1, 1973
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemiaP Dombernowsky, N I Nissen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Controversies in the management of Hodgkin's diseaseN I Nissen, D Hovgaard
European Journal of Haematology|May 1, 1988
Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combinationL Specht, N I Nissen
European Journal of Cancer|March 1, 1976
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemiaP Dombernowsky, N I Nissen
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Ugeskrift for Laeger|June 25, 1973
[Vincristine sulfas (Oncovin), a cytostatic agent]N I Nissen
Antibiotics and Chemotherapy|January 1, 1978
Chemotherapy with or without radiotherapy in malignant lymphomasN I Nissen
Ugeskrift for Laeger|June 19, 1972
[Evaluation of the clinical effect of antineoplastic drugs]N I Nissen
Nordisk Medicin|April 22, 1971
[Clinically controlled research in tumor chemotherapy]N I Nissen
European Journal of Haematology|July 1, 1988
Prognostic factors in Hodgkin's disease stage III with special reference to tumour burdenL Specht, N I Nissen
Ugeskrift for Laeger|June 19, 1972
[Vinca alkaloids, a newer group of anti-neoplastic drugs]I Hansen, N I Nissen
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|September 1, 1973
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemiaP Dombernowsky, N I Nissen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Controversies in the management of Hodgkin's diseaseN I Nissen, D Hovgaard
European Journal of Haematology|May 1, 1988
Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combinationL Specht, N I Nissen
European Journal of Cancer|March 1, 1976
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemiaP Dombernowsky, N I Nissen
Pageof 16